Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Clinical and Molecular Hepatology
|
December 12, 2022
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Asako Nogami, Masato Yoneda, Michihiro Iwaki, et al.
Nutrients
|
March 11, 2023
Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, et al.
Journal of Gastroenterology
|
October 16, 2023
Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, et al.
Clinical Journal of Gastroenterology
|
April 19, 2023
Mortality associated with the development of acute liver failure after a single dose of nivolumab
Asako Nogami, Naohiro Wada, Erika Muraoka, et al.
Scientific Reports
|
January 25, 2025
Lactiplantibacillus plantarum 22 A-3 ameliorates leaky gut in mice through its anti-inflammatory effects
Takashi Kobayashi, Takaomi Kessoku, Michihiro Iwaki, et al.
Tomography (Ann Arbor, Mich.)
|
April 26, 2024
Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis
Shingo Koyama, Asako Nogami, Masato Yoneda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
September 8, 2025
Efficacy of Magnetic Resonance Elastography in Fontan-Associated Liver Disease
Michihiro Iwaki, Takashi Kobayashi, Naohiro Wada, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
April 25, 2025
Prior Immune Checkpoint Inhibitor Treatment Is a Risk Factor for Treatment-Related Adverse Events in Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab
Naohiro Watanabe, Takashi Kobayashi, Michihiro Iwaki, et al.
Hepatology Communications
|
May 17, 2022
Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial
Masato Yoneda, Takashi Kobayashi, Yasushi Honda, et al.
Journal of Gastroenterology and Hepatology
|
November 27, 2022
Real-world assessment of SmartExam, a novel FibroScan computational method: A retrospective single-center cohort study
Asako Nogami, Michihiro Iwaki, Takashi Kobayashi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Clinical and Molecular Hepatology
|
December 12, 2022
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Asako Nogami, Masato Yoneda, Michihiro Iwaki, et al.
Nutrients
|
March 11, 2023
Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, et al.
Journal of Gastroenterology
|
October 16, 2023
Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, et al.
Clinical Journal of Gastroenterology
|
April 19, 2023
Mortality associated with the development of acute liver failure after a single dose of nivolumab
Asako Nogami, Naohiro Wada, Erika Muraoka, et al.
Scientific Reports
|
January 25, 2025
Lactiplantibacillus plantarum 22 A-3 ameliorates leaky gut in mice through its anti-inflammatory effects
Takashi Kobayashi, Takaomi Kessoku, Michihiro Iwaki, et al.
Tomography (Ann Arbor, Mich.)
|
April 26, 2024
Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis
Shingo Koyama, Asako Nogami, Masato Yoneda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
September 8, 2025
Efficacy of Magnetic Resonance Elastography in Fontan-Associated Liver Disease
Michihiro Iwaki, Takashi Kobayashi, Naohiro Wada, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
April 25, 2025
Prior Immune Checkpoint Inhibitor Treatment Is a Risk Factor for Treatment-Related Adverse Events in Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab
Naohiro Watanabe, Takashi Kobayashi, Michihiro Iwaki, et al.
Hepatology Communications
|
May 17, 2022
Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial
Masato Yoneda, Takashi Kobayashi, Yasushi Honda, et al.
Journal of Gastroenterology and Hepatology
|
November 27, 2022
Real-world assessment of SmartExam, a novel FibroScan computational method: A retrospective single-center cohort study
Asako Nogami, Michihiro Iwaki, Takashi Kobayashi, et al.
Page
of 5